Abstract:Background: Nitric Oxide (NO) has recently gained recognition as a promising approach in the field of cancer therapy. The quinoline scaffold is pivotal in cancer drug research and is known for its versatility and diverse mechanisms of action. Objective: This study presents the synthesis, characterization, and evaluation of novel quinoline nitrate derivatives as potential anticancer agents. Methods: The compounds were synthesized through a multi-step process involving the preparation of substituted 1-(2-aminophenyl) ethan-1-one, followed by the synthesis of substituted 2- (chloromethyl)-3,4-dimethylquinolines, and finally, the formation of substituted (3,4- dimethylquinolin-2-yl) methyl nitrate derivatives. The synthesized compounds were characterized using various spectroscopic techniques. Molecular docking studies were conducted to assess the binding affinity of the compounds to the EGFR tyrosine kinase domain. Results: The docking scores revealed varying degrees of binding affinity, with compound 6k exhibiting the highest score. The results suggested a correlation between molecular docking scores and anticancer activity. Further evaluations included MTT assays to determine the cytotoxicity of the compounds against Non-Small Cell Lung Cancer (A-549) and pancreatic cancer (PANC-1) cell lines. Compounds with electron-donating groups displayed notable anticancer potential, and there was a correlation between NO release and anticancer activity. The study also investigated nitric oxide release from the compounds, revealing compound 6g as the highest NO releaser. Conclusion: The synthesized quinoline nitrate derivatives showed promising anticancer activity, with compound 6g standing out as a potential lead compound. The correlation between molecular docking, NO release, and anticancer activity suggests the importance of specific structural features in the design of effective anticancer agents.

Synthesis and biological evaluation of nitric oxide-donating thalidomide analogues as anticancer agents.

Synthesis and Biological Evaluation of Novel Thalidomide Analogues As Potential Anticancer Drugs

Synthesis and Anti-Tumor Activities of Nitrate Derivatives of Glycyrrhetinic Acid

Design, Synthesis, and Biological Evaluation of Novel Nitric Oxide Releasing Dehydroandrographolide Derivatives.

Synthesis and Antitumor Activity of Nitric Oxide-Donating Glycyrrhetinic Acid Derivatives Coupled with Nitrate Moiety

Synthesis and Bioactivity of Novel Phthalimide Derivatives

Synthesis and Biological Evaluation of Nitric Oxide-Releasing Sixalkoxyl Biphenyl Derivatives As Anticancer Agents

Discovery of New Immunomodulatory Anticancer Thalidomide Analogs: Design, Synthesis, Biological Evaluation and In Silico Studies

Synthesis and Biological Evaluation of Nitrate Derivatives of Thiocolchicine as Potential Anticancer Drugs

Synthesis and Primary Anti-tumor Activities of 3-Fluoro-or 3-Amino-6-substituted-5,6-dihydropyrrolo [3,4-b] pyridin-7-ones

Synthesis and Cytotoxic Evaluation of Novel Dimethyl [1,1′‐biphenyl]‐2,2′‐dicarboxylates Bearing 1,3,4‐thiadiazole Moieties

Novel Nitric Oxide-Releasing Spirolactone-Type Diterpenoid Derivatives with in Vitro Synergistic Anticancer Activity As Apoptosis Inducer

New immunomodulatory anticancer quinazolinone-based thalidomide analogs: design, synthesis and biological evaluation

Novel Quinoline Nitrate Derivatives: Synthesis, Characterization, and Evaluation of their Anticancer Activity with a Focus on Molecular Docking and NO Release

Synthesis and Anti-cancer Activity of Nitric Oxide Donor-based Matrine Derivatives

Design, Synthesis, and Biological Evaluation of a Class of TEMPOmodified Naphthalimide Derivatives with Good Selectivity for Tumor Cells

Synthesis and Antiproliferative Activity of Novel 1,3,4-Thiadiazole Derivatives

Design, Synthesis, and Antitumor Evaluation of Novel Naphthalimide Derivatives

Synthesis, Preliminary Structure-Activity Relationships, and in Vitro Biological Evaluation of 6-Aryl-3-amino-thieno[2,3-b]pyridine Derivatives As Potential Anti-Inflammatory Agents.

Synthesis and antitumor activity of NO-donating retinoids

Novel Anticancer Oridonin Derivatives Possessing a Diazen-1-ium-1,2-diolate Nitric Oxide Donor Moiety: Design, Synthesis, Biological Evaluation and Nitric Oxide Release Studies.